Evidence map›Paper›PMID 39372929›Full record

ArticleResearch square2024

See Me, Hear Me: Racial Discrimination Among Women Seeking Breast Cancer Care.

Naomi Ko, Lauren Oshry, Ruth Lederman, Haley Gagnon, Tsion Fikre, Daniel Gundersen, Anna Revette, Ashley Odai-Afotey, Olga Kantor, Dawn Hershman and 3 more

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Naomi KoBoston University School of Medicine/Boston Medical Center.ORCID https://orcid.org/0000-0001-9689-9601
Lauren OshryBoston University School of Medicine/Boston Medical Center.
Ruth LedermanDana-Farber Cancer Institute.
Haley GagnonDana-Farber Cancer Institute.
Tsion FikreBoston University School of Medicine/Boston Medical Center.
Daniel GundersenDana-Farber Cancer Institute.
Anna RevetteDana-Farber Cancer Institute.
Ashley Odai-AfoteyDana-Farber Cancer Institute; Brigham and Women's Hospital.
Olga KantorBrigham and Women's Hospital.
Dawn HershmanColumbia University Irving Medical Center, Hervert Irving Comprehensive Cancer Center.
Katherine CrewColumbia University.ORCID https://orcid.org/0000-0002-9637-2962
Nancy KeatingBrigham and Women's Hospital; Harvard Medical School.
Rachel FreedmanDana Farber Cancer Institute.

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
NCI NIH HHS P30 CA013696
6 · The paper itself

Abstract

Discrimination can contribute to worse health outcomes, but its prevalence in breast cancer is not well studied. We aimed to understand how women with stage I-III breast cancer faced discrimination in health care and everyday settings through a cross-sectional survey. 296 women, 178 (60%) Non-Hispanic White (NHW), 76 (26%) Non-Hispanic Black (NHB), and 42 (14%) Hispanic participated. NHB women reported significantly more discrimination in everyday life compared to NHW women (score 20.1 vs 16.1, p<.001) and Hispanic women (score 20.1 vs 16.0, p<.001). In the health care setting, NHB had statistically more frequent reports of being ignored (23.7% vs. 5.6%), treated with less respect (21.1% vs. 7.3%), and treated with less courtesy (18.7% vs. 6.2%; all P=<.001) when compared to NHW women. NHB women experience a higher degree of discrimination both inside and outside of health care. Further research to understand discrimination on breast cancer outcomes is warranted.

Identifiers

PMID39372929
PMCPMC11451816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.